Abstract
We describe our experience of setting up an allogeneic BMT program at the Christian Medical College Hospital, Vellore over a period of 13 years, from October 1986 to December 1999. Two hundred and twenty-one transplants were performed during this period in 214 patients, with seven patients undergoing second transplants. Indication for BMT were thalassemia major – 106 (48%), CML – 30, AML – 35, ALL – 10, SAA – 22, MDS – six and six for other miscellaneous disorders. The mean age of this patient cohort was 15.6 years (range 2–52). Graft-versus-host disease of grades III and IV was seen in 36 patients (17%) and this was the primary cause of death in 20 patients (9.2%). All patients and donors were CMV IgG positive. Sepsis was the primary cause of death in 16 patients (7.4%), 10 bacterial, four fungal and two viral. One hundred and ten of this series of patients are alive and disease free (50%) with a median follow-up of 24 months (range 2–116). These results are comparable to those achieved for patients with similar disease status in transplant units in the Western world and cost a mean of US$15 000. Bone Marrow Transplantation (2001) 27, 785–790.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Rizzo D . New summary slides show current trends in BMT ABMTR Newsletter 1998 5: 4–10
Amyes SGB, Tait S, Thomson CJ et al. The incidence of antibiotic resistance in aerobic fecal flora in South India J Antimicrob Chemother 1992 29: 415–425
Tutschka PJ, Copelan EA, Klein JP . Bone marrow transplantation for leukemia following a new busulphan and cyclophosphamide regime Blood 1987 70: 1382–1388
Storb R, Etzioni R, Anasetti C et al. Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia Blood 1994 84: 941–949
Storb R, Deeg HJ, Farewell K et al. Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for preventing acute graft versus host disease Blood 1986 68: 119–125
Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft versus host disease in human recipients of marrow from HLA matched sibling donors Transplantation 1974 18: 295–304
Srivastava VM, Krishnaswami H, Srivastava A et al. Infections in haematological malignancies: an autopsy study of 72 cases Trans R Soc Trop Med Hyg 1996 90: 406–408
Ho WG, Champlin RE, Feig SA, Gale RP . Transplantation of ABH incompatible bone marrow: gravity sedimentation of donor marrow Br J Haematol 1984 57: 155–162
Pugatsch T, Oppenheim A, Slavin S . Improved single-step PCR assay for sex identification post-allogeneic sex-mismatched BMT Bone Marrow Transplant 1996 17: 273–275
Thomas ED, Buckner CD, Sanders JE et al. Marrow transplantation for thalassemia Lancet 1982 ii: 227–229
Lucarelli G, Galimberti M . Bone marrow transplantation – the experience of Pesaro, Italy Educational Suppl ISH Singapore 1996 18–21
Lucarelli G, Galimberti M, Polchi P et al. Marrow transplantation for patients with thalassemia New Engl J Med 1990 322: 417–421
Gale RP, Horowitz MM, Rees JK et al. Chemotherapy vs transplants for acute myelogenous leukemia in second remission Leukemia 1996 10: 13–19
Champlin RE, Schmitz N, Horowitz MM et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation Blood 2000 95: 3702–3709
Gale RP, Hehlmann R, Zhang MJ et al. Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia. The German CML Study Group MM CML Blood 1998 91: 1810–1819
Kloke O, Opalka B, Niederle N . Interferon alfa as primary treatment of chronic myeloid leukemia: long term follow-up of 71 patients observed in a single center Leukemia 2000 14: 389–392
Horowitz MM, Rowlings PA, Passweg JR . Allogeneic bone marrow transplantation for CML: a report from the International Bone Marrow Transplant registry Bone Marrow Transplant 1997 17: (Suppl. 3) S5–S8
Zhang MJ, Hoelzer D, Horowitz MM et al. Long-term follow-up of adults with acute lymphoblastic leukemia in first remission treated with chemotherapy or bone marrow transplantation. The Acute Lymphoblastic Leukemia Working Committee Ann Intern Med 1995 123: 428–431
Storb R, Thomas ED, Buckner CD et al. Marrow transplantation in thirty ‘untransfused’ patients with severe aplastic anemia Ann Intern Med 1980 92: 30–36
Bean MA, Graham T, Appelbaum FR . Gamma-irradiation of pretransplant blood transfusions from unrelated donors prevents sensitization to minor histocompatibility antigens on dog leukocyte antigen-identical canine marrow grafts Transplantation 1994 57: 423–426
Mathew LG, Chandy M, Dennison D et al. Successful bone marrow transplantation in an infant with Wiskott–Aldrich syndrome Indian Pediat 1999 36: 707–710
Dennison D, Vaughan WP, Chandy M et al. Bone marrow transplantation in India: appropriate or inappropriate technology? Int Third World Studies J Rev 1990 2: 1–5
Acknowledgements
This work would not have been possible without the active support of many departments in the institution: Clinical Pathology and Blood Bank, Microbiology, Virology, Biochemistry, General Surgery, Pediatric Surgery and Radiotherapy. The dedication and professionalism of the transplant nurses, registrars and laboratory faculty essential for the success of the program is gratefully acknowledged. We thank the Indian Council of Medical Research for supporting us with an Advanced Center for Bone Marrow Transplantation in thalassemia, Dr KF Bradstock (Westmead, Australia) and Dr William Vaughan (Alabama, US) for faculty training.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chandy, M., Srivastava, A., Dennison, D. et al. Allogeneic bone marrow transplantation in the developing world: experience from a center in India. Bone Marrow Transplant 27, 785–790 (2001). https://doi.org/10.1038/sj.bmt.1702869
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702869
Keywords
This article is cited by
-
Idiopathic Aplastic anemia: Indian Perspective
Indian Journal of Hematology and Blood Transfusion (2023)
-
Building a hematopoietic cell transplantation outcomes registry in Mexico
Bone Marrow Transplantation (2020)
-
Pediatric Hematopoietic Stem Cell Transplantation in India: Status, Challenges and the Way Forward
The Indian Journal of Pediatrics (2017)
-
The Latin American experience of allografting patients with severe aplastic anaemia: real-world data on the impact of stem cell source and ATG administration in HLA-identical sibling transplants
Bone Marrow Transplantation (2017)
-
Peripheral blood versus bone marrow transplant in patients with aplastic anemia, an unresolved issue
Bone Marrow Transplantation (2016)